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A new catheter to simplify portal vein cannulation for adjuvant cytotoxic
liver perfusion following resection of rectal cancer
S. Ashley, G. Sutton, G. Royle & I. Taylor
University Surgical Unit, Royal South Hampshire Hospital, Southampton, UK.
Summary Evidence from randomised clinical trials suggests that adjuvant cytotoxic liver perfusion with
5-fluorouracil following resection of colorectal carcinoma may improve survival in some patients. Various
methods of cannulating the portal vein or a tributary at the time of surgery have been described. We describe
a simple method of accessing the portal venous circulation via a tributary in the small bowel mesentery,
employing a new type of polyurethane catheter. The technical details are discussed with reference to previous
literature.
Adjuvant cytotoxic liver perfusion with 5-fluorouracil (5-FU)
after resection of colorectal carcinoma has become an estab-
lished form of treatment on our unit following the encourag-
ing results of randomised trials (Taylor et al., 1985; Gray et
al., 1987). The technique involves cannulation of a portal
vein tributary at the time of colorectal resection. The catheter
is brought out through the abdominal wall thus providing
access to the portal venous circulation for postoperative per-
fusion with the cytotoxic agent.
The initial technique used was to cannulate the
'obliterated' umbilical vein at the time of surgery and check
the position of the catheter by venography. A stiff
polyethylene catheter was employed but was prone to
blockage and its insertion often proved to be difficult, time-
consuming and sometimes impossible. Alternative simpler
methods of cannulation of the hepatic portal vein via the
mesenteric veins or their tributaries have been described
(Hunt & Windle, 1986; Hardy et al., 1984).
Experience with a thin-walled 16 gauge polyurethane
catheter (Viggo Secalon Universal) has shown it to be
invaluable in the management of patients requiring long-term
venous access for parenteral nutrition and chemotherapy
(Sutton, 1987). This catheter is strong, flexible and non-
thrombogenic and is ideally suited for insertion into a small
tributary of the superior mesenteric vein. It provides a tech-
nically straightforward means of access to the portal venous
circulation.
Materials and methods
Following colorectal resection and anastomosis, a convenient
loop of small bowel is held up and 'back-lighted' to display
the vascular arcades. A vein in the periphery of the
mesentery is exposed by creating a small window in the
peritoneum and held up between two slings. Usually, no
difficulty is encountered in distinguishing vein from artery.
The catheter is passed through the abdominal wall at a site
remote from the incision using a standard catheter introducer
which is then removed. The catheter hub is attached and
secured with the locknut and the line flushed with saline.
A small venotomy is made with fine scissors and the
catheter is introduced and passed proximally until its tip is
palpable in the portal vein within the free border of the lesser
omentum. This avoids the theoretical risk of small bowel
ulceration if the catheter happens to enter a small tributary
of the superior mesenteric vein. A silk tie is used to secure
the catheter and the distal vein is ligated. It should be
possible to obtain a flush-back of portal venous blood into a
syringe, and the line is then flushed with normal saline/
heparin. Silk is used to secure the catheter to the skin. (A
schematic diagram of the catheter within the portal venous
system is shown in Figure 1.) A similar technique can be used
for cannulating the gastro-epiploic vein just proximal to the
pylorus.
5-FU perfusion is commenced intra-operatively and con-
tinued for the first 7 postoperative days. Removal of the
catheter is simply a case of pulling it out gently on the ward.
Results
We have not encountered problems with line blockage or
thrombosis in 27 consecutive patients and no longer routinely
check the position of the line radiologically. The increase in
operative time taken to insert this portal vein catheter is on
average Omin. So far no problems or complications have
occurred on catheter removal.
Discussion
If 5-FU perfusion following resection of colorectal cancer is
to be widely practised, then difficulties and complications
associated with the insertion and use of portal venous
catheters must be minimal. The method described has so far
proved to be technically straightforward and uncomplicated
in our hands.
Figure 1 Schematic diagram showing catheter passing through
abdominal wall into tributary of superior mesenteric vein at the
periphery of the small bowel mesentery. The catheter is advanced
until it is palpable in the portal vein within the free edge of the
lesser omentum.
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